Evaluation of the Usefulness to Doctors of the Risperdal Consta Treatment Guidebook Over a Three-month Period During Which Adult Patients With Schizophrenia or Schizoaffective Disorder Are Switching From Daily Doses or Risperidone Tablets to Long-acting Risperidone by Injection
PHASE3CompletedINTERVENTIONAL
Enrollment
1
Participants
Timeline
Start Date
Not specified
Study Completion Date
January 31, 2003
Conditions
SchizophreniaPsychotic Disorders
Interventions
DRUG
risperidone
All Listed Sponsors
collaborator
Janssen, LP
INDUSTRY
lead
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.